Barton GR, Briggs AH, Fenwick EA: Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value in Health 2008, 11(5):886-897.
Article
Google Scholar
Baxter NN, Virnig BA, Durham SB, Tuttle TM: Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 2004, 96(6):443-448.
Article
Google Scholar
Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al.: Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005, 353(17):1784-1792.
Article
Google Scholar
Bluekens AM, Karssemeijer N, Beijerinck D, Deurenberg JJ, van Engen RE, Broeders MJ, et al.: Consequences of digital mammography in population-based breast cancer screening: initial changes and long-term impact on referral rates. Eur Radiol 2010, 20(9):2067-2073.
Article
Google Scholar
Bray F, Jemal A, Grey N, Ferlay J, Forman D: Global cancer transitions according to the human development index (2008–2030): a population-based study. Lancet Oncol 2012, 13(8):790-801.
Article
Google Scholar
Buist DS, Porter PL, Lehman C, Taplin SH, White E: Factors contributing to mammography failure in women aged 40–49 years. J Natl Cancer Inst 2004, 96(19):1432-1440.
Article
Google Scholar
Butler JR, Furnival CM, Hart RF: Estimating treatment cost functions for progressive diseases: a multiproduct approach with an application to breast cancer. J Health Econ 1995, 14(3):361-385.
Article
Google Scholar
Cady B: Cost-effective preoperative evaluation, operative treatment, and postoperative follow-up in the breast cancer patient. Surg Clin North Am 1996, 76(1):25-34.
Article
Google Scholar
Cody B: An ethnohistory of a granny midwife. J Transcultural Nurs 1996, 8(1):13-18.
Article
Google Scholar
Cruz LN: Medidas de Qualidade de Vida e Utilidade em uma Amostra da População de Porto Alegre. Porto Alegre, Brazil: Thesis (PhD in Epidemiology) Federal University of Rio Grande do Sul (. UFRGS); 2010.
Google Scholar
DATASUS: Sistema de Informação sobre Mortalidade (SIM) 1996–2000. Brazil: Ministério da Saúde; 2000.
Google Scholar
de Oliveira B, Lombardo V, Gotlieb SLD, de Souza JMP: Sobrevida de Pacientes com Câncer no Estado de São Paulo: Seis Anos de Seguimento pelo Registro Hospitalar de Câncer, F.O.d.S.P. São Paulo, Brazil: FOSP, Secretária de Estada da Saúde de São Paulo; 2009.
Google Scholar
Dowsett M, Cuzick J, Ingle J, Coates A, Forbes J, Bliss J, et al.: Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen. J Clin Oncol 2010, 28(3):509-518.
Article
Google Scholar
Edge SB, Byrd DR, Compton CC: AJCC (American joint committee on cancer) cancer staging manual. 7th edition. New York: Springer-Verlag; 2010.
Google Scholar
Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R: Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 2000, 160(7):953-958.
Article
Google Scholar
Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O’Shea MK, et al.: Cost-effectiveness of HPV 16, 18 vaccinations in Brazil. Vaccine 2007, 25(33):6257-6270.
Article
Google Scholar
Goldie SJ, Diaz M, Kim SY, Levin CE, Van Minh H, Kim JJ: Mathematical models of cervical cancer prevention in the Asia Pacific region. Vaccine 2008, 26(Suppl 12):M17-M29.
Article
Google Scholar
Hassett MJ, O’Malley AJ, Pakes JR, Newhouse JP, Earle CC: Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 2006, 98(16):1108-1117.
Article
Google Scholar
Hillner BE: Economic and cost-effectiveness issues in breast cancer treatment. Semin Oncol 1996, 23(1 Suppl 2):98-104.
Google Scholar
Hirsch A, Kachnic LA, Sabel MS, In: UpToDate: Management of locoregional recurrence of breast cancer after breast conserving therapy. UpToDate, Waltham, MA: Gralow, JR (Ed); 2011.
Google Scholar
Hirsch A, Kachnic LA, Sabel MS, Hayes D, In: UpToDate: Management of locoregional recurrence of breast cancer after mastectomy. UpToDate, Waltham, MA: Gralow, JR (Ed); 2011.
Google Scholar
Hortobagyi GN: Treatment of breast cancer. N Engl J Med 1998, 339(14):974-984.
Article
Google Scholar
IBGE: XII Censo Demográfico. Brazil: IBGE, Editor; 2010.
Google Scholar
INCA: Mamografia: da prática ao controle. Recomendações para profissionais de saúde. Rio de Janeiro, Brazil: Ministério da Saúde; 2007.
Google Scholar
INCA: Estimativa da incidência de Câncer para 2008 no Brasil e nas cinco Regiões. 2008. . Jul 24, 2013 http://www.inca.gov.br/conteudo_view.asp?id=1793
Google Scholar
INCA: Publisher name. Ministério da Saúde do Brasil: Programa de Qualidade em Mamografia - PQM; 2009. http://www.inca.gov.br/releases/press_release_view.asp?ID=2032
Google Scholar
INCA: Ministério da Saúde do Brasil. Rio de Janeiro, Brazil: O Câncer de Mama no Brasil - Situação Epidemiológica e rastreamento, in Encontro interncional sobre rastreamento de câncer de mama; 2009.
Google Scholar
INCA: Câncer no Brasil. Rio de Janeiro, Brazil. Câncer no Brasil: Dados dos Registros de Base Populacional: Dados dos Registros de Base Populacional, C.d.P.e. Vigilância, Editor 2010, Ministério da Saúde; 2010.
Google Scholar
INCA: Panorama da Assistência Oncológica no Sistema Único de Saúde a partir das Informações do Integrador RHC, D.d.I.e.A.d. Rio de Janeiro, Brazil: Situação. Coordenação Geral de Ações Estratégicas; 2011.
Google Scholar
Jakubowski AA, et al.: Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma. Clin Can Res 1996, 2(2):295-302.
Google Scholar
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008, 58(2):71-96.
Article
Google Scholar
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90.
Article
Google Scholar
Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, et al.: Metastatic behavior of breast cancer subtypes. J Clin Oncol 2010, 28(20):3271-3277.
Article
Google Scholar
Kerlikowske K: Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010, 41: 139-141.
Article
Google Scholar
Kerlikowske K, Hubbard RA, Miglioretti DL, Geller BM, Yankaskas BC, Lehman CD, et al.: Comparative effectiveness of digital versus film-screen mammography in community practice in the United States: a cohort study. Ann Intern Med 2011, 155(8):493-502.
Article
Google Scholar
Legorreta AP, Brooks RJ, Leibowitz AN, Solin LJ: Cost of breast cancer treatment. A 4-year longitudinal study. Arch Intern Med 1996, 156(19):2197-2201.
Article
Google Scholar
Lilliu H, Stevens D, Brun C, Morel J, Pen CL, Bonastre J, et al.: Cost of treatment and follow up of breast cancer: a retrospective assessment in a comprehensive cancer centre. Bulletin du Cancer 2002, 89(6):635-642.
Google Scholar
Lindfors KK, Rosenquist CJ: The cost-effectiveness of mammographic screening strategies. JAMA 1995, 274(11):881-884.
Article
Google Scholar
Lu W, Greuter MJ, Schaapveld M, Vermeulen KM, Wiggers T, de Bock GH: Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment. Brit J Surg 2012, 99(9):1227-1233.
Article
Google Scholar
Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Konnig HJ, Draisma G, et al.: Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009, 151(10):738-747.
Article
Google Scholar
Marchi AA, Gurgel MS: Adherence to the opportunistic mammography screening in public and private health systems. Rev Bras Ginecol Obstet 2010, 32(4):191-197.
Article
Google Scholar
Martins E, Freitas R Jr, Curado MP: Temporal evolution of breast cancer stages in a population-based cancer registry in the Brazilian central region. Rev Bras Ginecol Obstet 2009, 315(5):5.
Google Scholar
Mauri D, Pavlidis N, Polyzos NP, Ioannidis JP: Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis. J Natl Cancer Inst 2006, 98(18):1285-1291.
Article
Google Scholar
Meijnen P, Oldenburg HS, Peterse JL, Bartelink H, Rutgers EJ: Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast. Ann Surg Oncol 2008, 15(1):235-243.
Article
Google Scholar
Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, et al.: American society of clinical oncology guidance statement: the cost of cancer care. J Clin Oncol 2009, 27(23):3868-3874.
Article
Google Scholar
Ministério_Saúde_Brasil: Diretrizes Metodológicas - Estudos de Avaliação Ecônomica de Tecnologias em Saúde, T.e.I.E. Brazil: Secretária de Ciência. Ministério da Saúde; 2009.
Google Scholar
Ministério_Saúde_Brasil, DATASUS 2011.http://www2.datasus.gov.br/DATASUS/index.php
Mook S, Van’t Veer LJ, Rutgers EJ, Ravdin PM, van de Velde AO, van Leeuwen FE, et al.: Independent prognostic value of screen detection in invasive breast cancer. J Natl Cancer Inst 2011, 103(7):585-597.
Article
Google Scholar
Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L: Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet 2006, 368(9552):2053-2060.
Article
Google Scholar
Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, et al.: Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group. J Clin Oncol 2001, 19(10):2596-2606.
Google Scholar
Mouridsen H, Gershanovich M, Sun Y, Perez-Carrion R, Boni C, Monnier A, et al.: Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol 2003, 21(11):2101-2109.
Article
Google Scholar
MS B: Avaliação do funcionamento dos mamográfos no âmbito do Sistema Único de Saúde - Grupo Nacional Força Tarefa, D.N.d.A.d. Brasilia, DF, Brasil: SUS, Editor; 2011.
Google Scholar
Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L: Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 151(10):727-737. W237–242
Article
Google Scholar
Okonkwo QL, Drasma G, der Kinderen A, Brown ML, de Koning HJ: Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst 2008, 100(18):1290-1300.
Article
Google Scholar
Perez EA, Romond EH, Suman VJ, Jeong JH, Davidson NE, Geyer CE Jr, et al.: Four-year follow-up of trastuzumab plus adjuvant chemotherapy for operable human epidermal growth factor receptor 2-positive breast cancer: joint analysis of data from NCCTG N9831 and NSABP B-31. J Clin Oncol 2011, 29(25):3366-3373.
Article
Google Scholar
Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, et al.: Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012, 379(9814):432-444.
Article
Google Scholar
Pisano ED, Hendrick RE, Yaffe MJ, Baum JK, Acharyya S, Cormack JB, et al.: Diagnostic accuracy of digital versus film mammography: exploratory analysis of selected population subgroups in DMIST. Radiology 2008, 246(2):376-383.
Article
Google Scholar
Rojnik K, Naversnik K, Mateovic-Rojnik T, Primiczakelj M: Probabilistic cost-effectiveness modeling of different breast cancer screening policies in Slovenia. Value Health 2008, 11(2):139-148.
Article
Google Scholar
Schopper D, de Wolf C: How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 2009, 45(11):1916-1923.
Article
Google Scholar
Skaane P, Hofvind S, Skjennald A: Randomized trial of screen-film versus full-field digital mammography with soft-copy reading in population-based screening program: follow-up and final results of Oslo II study. Radiology 2007, 244(3):708-717.
Article
Google Scholar
Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, et al.: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001, 344(11):783-792.
Article
Google Scholar
Smith RA, Duffy S: Over diagnosis in breast cancer screening: methodological considerations of current estimates. Supplement to Cancer Research 2011, 71(24):658.
Google Scholar
Souza FH: Mamografia Digital em Comparação com Mamografia Convencional no Rastreamento do Câncer de Mama no Brasil: Revisão Sistemática, Custo da Doença e Análise de Custo-Efetividade no Sistema Único de Saúde. Porto Alegre, Brazil: Thesis (PhD in Epidemiology), Federal University of Rio Grande do Sul (UFRGS); 2012.
Google Scholar
Souza FH, Wendland EM, Rosa MI, Polanczyk : Full-field digital mammography is not more accurate than screen-film mammography in population screening: a systematic review and meta-analysis. Breast 2013, 22(3):217-224.
Article
Google Scholar
Szeto KL, Devlin NJ: The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. Health Policy 1996, 38(2):101-115.
Article
Google Scholar
Tabar L, Dean PB: Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer. Breast Cancer Res 10 2008, 4(Suppl):S3.
Article
Google Scholar
Tice JA, Feldman MD: Full-field digital mammography compared with screen-film mammography in the detection of breast cancer: rays of light through DMIST or more fog? Breast Cancer Res Treat 2008, 107(2):157-165.
Article
Google Scholar
Tosteson AN, Stout NK, Fryback DG, Acharyya S, Herman BA, Hannah LG, et al.: Cost-effectiveness of digital mammography breast cancer screening. Ann Intern Med 2008, 148(1):1-10.
Article
Google Scholar
US Preventive Services Task Force: Screening for breast cancer: U.S. Preventive services task force recommendation statement. Ann Intern Med 2009, 151(10):716-726. W–236
Article
Google Scholar
van Oortmarssen GJ, Habbema JD, van der Maas PJ, de Koning HJ, Collete HJ, Verbeek AJ, et al.: A model for breast cancer screening. Cancer 1990, 66(7):1601-1612.
Article
Google Scholar
Vanni T, Legood R, White RG: Calibration of disease simulation model using an engineering approach. Value in Health 2010, 13(1):157.
Article
Google Scholar
Vanni T, Luz PM, Grinsztejn B, Veloso VG, Foss A, Mesa-Frias M, et al.: Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country. Int J Cancer 2012, 131(2):E96-E104.
Article
Google Scholar
Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JHTan-Chiu E, et al.: Prognosis after ipsilateral breast tumor recurrence and loco regional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials. J Clin Oncol 2006, 24(13):2028-2037.
Article
Google Scholar
Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, et al.: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011, 103(6):478-488.
Article
Google Scholar
World Health Organization: Commission on macroeconomics and health: investing in health for economic development. Geneva: World Health Organization; 2001.
Google Scholar